Skip to main content

Table 3 Frequency of dhfr and dhps mutant alleles, genotypic study, Lainé refugee camp

From: Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

Genotype Frequencies

n

%

95% CI

dhps (N = 114)

   

wild type,

8

7.0

3.1–13.6

single mutant 436

31

27.2

19.3–36.3

single mutant 437

38

33.3

24.8–42.8

double mutant 436–437

29

25.4

17.7–34.4

double mutant 437–540

8

7.0

3.1–13.6

dhfr (N = 148)

   

wildtype

20

13.5

8.4–20.1

double mutant 59–108

2

1.4

0.2–4.8

triple mutant 51–59–108

126

85.1

78.4–90.4

dhps and dhfr combined (N = 110)

   

quintuple mutant: dhfr 51–59–108 &dhps 437–540

8

7.3

3.2–13.8

quintuple mutant: dhfr 51–59–108 & dhps 436–437

27

24.5

16.8–33.7

dhfr 51–59–108 & dhps single mutant

54

49.1

39.4–58.8

Three or less mutations

21

19.1

12.2–27.7

  1. Dhfr: dihydrofolate reductase
  2. Dhps: dihydropterase synthetase